| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.0M | -21.1% |
| SG&A Expense | $4.5M | -3.8% |
| Operating Income | -$11.5M | +15.2% |
| Pre-tax Income | -$11.5M | +13.6% |
| Income Tax | $0 | — |
| Net Income | -$11.5M | +13.6% |
| EPS (Basic) | -$10.10 | +18.7% |
| EPS (Diluted) | -$10.10 | +18.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $12.4M | -49.7% |
| Total Assets | $12.8M | -49.1% |
| Current Liabilities | $1.9M | -36.8% |
| Total Liabilities | $2.0M | -39.0% |
| Stockholders' Equity | $10.8M | -50.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.1M | -2.3% |
| Capital Expenditures | $121K | +137.3% |
| Investing Cash Flow | -$121K | -137.3% |
| Financing Cash Flow | -$26K | -100.1% |
| Free Cash Flow | -$12.3M | -2.9% |